Andra AP fonden Takes $27.96 Million Position in CVS Health Corporation $CVS

Andra AP fonden bought a new position in shares of CVS Health Corporation (NYSE:CVS) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought 370,800 shares of the pharmacy operator’s stock, valued at approximately $27,955,000.

Other hedge funds have also added to or reduced their stakes in the company. SOA Wealth Advisors LLC. increased its holdings in shares of CVS Health by 36.9% in the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 131 shares during the last quarter. Alteri Wealth LLC boosted its holdings in shares of CVS Health by 3.2% during the 3rd quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock worth $316,000 after buying an additional 131 shares during the period. Holistic Financial Partners grew its stake in CVS Health by 4.1% in the 3rd quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock valued at $256,000 after buying an additional 133 shares during the last quarter. Symmetry Partners LLC raised its holdings in CVS Health by 2.5% in the 3rd quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock valued at $439,000 after acquiring an additional 141 shares during the period. Finally, Harbor Capital Advisors Inc. lifted its position in CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 142 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the topic of several research reports. Evercore upped their target price on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Mizuho boosted their price target on CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. The Goldman Sachs Group lifted their target price on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Finally, Jefferies Financial Group upped their price target on shares of CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Nineteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus target price of $94.91.

CVS Health Stock Up 2.4%

Shares of CVS opened at $77.99 on Friday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. CVS Health Corporation has a 52 week low of $58.35 and a 52 week high of $85.15. The stock has a market capitalization of $99.22 billion, a price-to-earnings ratio of 56.51, a PEG ratio of 0.80 and a beta of 0.50. The stock has a fifty day moving average of $78.35 and a 200-day moving average of $77.02.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. During the same quarter last year, the business earned $1.19 EPS. The firm’s quarterly revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, sell-side analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio is presently 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.